Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe page shows a new revision tag, updating the version from v3.6.2 to v3.6.3, reflecting a small administrative update to the page. It does not alter the substantive content of the study record.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2, indicating a recent update to the site's content or framework. This change does not alter the primary study information displayed on the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment header formatting, plus a revised version tag (Revision: v3.6.0). It also states that the study is no longer recruiting participants.SummaryDifference0.3%

- Check31 days agoChange DetectedThe revision tag on the page changes from v3.5.4 to v3.5.5, indicating a software/maintenance update to the site. It does not modify study content or other user-visible information.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a backend/metadata change. There is no indication of changes to the visible content or layout.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page’s footer revision label has been updated from **v3.5.2** to **v3.5.3**, reflecting a minor update to the site software/display version without altering the underlying study record details.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.